#USA #Pittsburgh #Patient Care #PANTHERx Rare #MMIT Award

PANTHERx Rare Pharmacy Earns 2026 MMIT Patient Choice Award

In an impressive achievement for patient care, PANTHERx® Rare Pharmacy has been recognized with the 2026 MMIT Patient Choice Award in the Independent Specialty Pharmacy category. This prestigious award ceremony took place at Asembia's AXS26 Summit, where the company received accolades for its unwavering commitment to patient satisfaction in the realm of rare diseases.

PANTHERx Rare distinguishes itself by providing vital access and support services tailored for individuals grappling with rare diseases. The MMIT Patient Choice Award evaluates various specialty pharmacies based on direct patient feedback, specifically measuring the average Net Promoter Score (NPS) derived from the Specialty Pharmacy Patient Satisfaction Survey. Excitingly, this marks the ninth consecutive time PANTHERx has garnered this accolade, highlighting the company’s continued success in delivering personalized care to its patients.

Bansi Nagji, the CEO of PANTHERx, expressed gratitude for this recognition, stating, "Earning the MMIT Patient Choice Award for the ninth time is a testament to the trust that rare disease patients and their families place in us every day. Every time we simplify a process, remove a barrier to therapy, or offer a moment of clarity and compassion, we can change someone's day—and often their trajectory. We are honored to be recognized by patients for that impact."

The operational model at PANTHERx has been designed with rare disease realities in mind, underscoring the importance of building long-term relationships, developing deep therapy-specific expertise, and ensuring coordinated efforts among patients, prescribers, and pharmaceutical manufacturers. Their experience-driven approach has been honed over the years, specializing in handling the complex and high-touch needs of their patients. This has enabled PANTHERx to establish trust and recognition from patients, who continue to reward them with their confidence.

PANTHERx Rare Pharmacy’s mission revolves around demystifying rare disease care by prioritizing the unique needs of each patient and therapy. The pharmacy’s team builds robust personal relationships with patients and partners. This systematic collaboration not only serves patients effectively but also reassures them that they are not alone in their journey.

Since its inception in 2011, even beginning humbly in a garage in Pittsburgh, PA, PANTHERx has become the largest independent rare pharmacy in the United States. The commitment to innovation, responsiveness, and meticulous attention to detail has enabled the company to thrive. Additionally, they have achieved extraordinary milestones, including being the first national pharmacy to earn dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and the Utilization Review Accreditation Commission (URAC).

PANTHERx exists in all 50 states, offering specialized access to rare disease therapies while ensuring that the personal touch is never lost in the process of care delivery. With nine MMIT Patient Choice Awards under their belt, including the honor for 2026, it’s clear that PANTHERx Rare Pharmacy continues to elevate the standard of personalized pharmacy care.

For those seeking further information or direct inquiries about their services, PANTHERx encourages individuals to visit www.pantherxrare.com or reach out to their marketing communications department at [email protected].